LIVE SESSION BRIEF Drug Manufacturers - General $138B Cap Quant: HOLD

Gilead Sciences Inc (GILD) — Live Session & Technical Brief

Updated Nov 19, 2026 5:06 PM ET · Prev Close $168.98

Pro Workspace
Last Session Price
$166.53 -1.45%
-$2.45 vs $168.98 prior close
Intraday Range
$164.80 – $169.16
Open $169.16
Relative Volume
0.81x Avg
4,959,723 sh
52-Week Range
$116.88 – $176.58
Benchmark Alpha
+0.51% vs SPY
+0.74% vs QQQ
20-Session Trend +6.7%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-1.45%) in Drug Manufacturers - General

Gilead Sciences Inc (GILD) is trading within a tight intraday band at $166.53 (-1.45%, 0.81x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, GILD is outperforming the S&P 500 by +0.51%. 14-day RSI stands at 55.8, keeping momentum in a bullish regime.

NEWS 70% Weight
How Investors Are Reacting To Gilead Sciences Gild Hiv Prevention Expansion

Gilead Sciences reported new clinical and access moves, including positive data for Livdelzi in primary biliary cholangitis and royalty-free licenses for investigational Ebola antiviral obeldesivir across 127 lower incom

TECHNICAL 68% Weight
Moving Average Structure: Bullish Alignment

Price ($166.53) trades relative to 20-day SMA ($166.80) and 50-day SMA ($156.82).

Volume Confirmation
LOW VOLUME (0.81x) Consolidation
Sub-average participation — monitor RVOL expansion above 1.2x.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

GILD outperforming the S&P 500 by +0.51%
GILD Session
-1.45%
$166.53
S&P 500 (SPY)
-1.96%
$715.87
Nasdaq 100 (QQQ)
-2.19%
$645.04
Healthcare (XLV)
-2.05%
$177.46
Alpha vs SPY: +0.51% Alpha vs QQQ: +0.74% Alpha vs XLV: +0.60%
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $167.58 · IV 33.3%

GILD Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($16,758)

Compare $16,758 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 33.3% ATM IV.

5-DAY BULLISH SWING Liq A

Dec 18 $170 / $180 Bull Call Spread

Buy 1x $170C · Sell 1x $180C · 31d

Net Entry $334 Debit
T+5d @ +5% Move +$214 (+64%)
Max Risk / Buffer $334 Capped
5d Edge & Liquidity 1.0x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $155 / $145 Bull Put Spread

Sell 1x $155P · Buy 1x $145P · 31d

Net Entry $145 Credit
Max Credit / Yield +$145 (+17.0% RoM)
Max Risk / Buffer -8.4% Cushion ($855 Mgn)
5d Edge & Liquidity 80% PoP · Liq A
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq A

Dec 18 $155P / $170-$180C Seagull

Sell 1x $155P · Buy 1x $170/$180C · 31d

Net Entry $139 Debit
T+5d @ +5% Move +$356 (+14.7% RoM)
Max Risk / Buffer -7.5% Put Cushion ($2,428 Mgn)
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Recent GILD Catalyst Headlines

Verified Wire

1–3 Day Expected Range & Key Level

48% Follow-Through
Lower Bound
$160.27
Short-term support band
Upper Bound
$172.79
Short-term resistance band
Key Inflection Level
$166.80 (20-day SMA resistance)

Monitor volume expansion above 1.5x RVOL around $166.80 (20-day SMA resistance) for directional breakout confirmation.

Technical Regime (GILD)

BULLISH MA TREND
RSI (14)
55.8
Bullish
20-Day SMA
$166.80
Below 20d
50-Day SMA
$156.82
Above 50d
MACD Signal
Bearish
MACD 3.60
ADX (14)
31.7
Strong trend
10d Momentum
-0.45
Soft 10-day momentum

Retail & Crowd Sentiment

Very Bullish
24h Messages
1
2.3x 7d avg
Bullish / Bearish
100.0% / 0.0%
Low buzz
Crowd Discussion Digest

The latest article discusses Alnylam's $1 billion buyback and its inability to significantly impact the stock price due to market concerns over the growth of Alnylam's main heart drug, Amvuttra. The stock has fallen sharply since its results day, with CEO Yvonne Greenstreet expressing dissatisfaction with the demand growth observed.

Reddit communities: 1 comment (Bullish)

About Gilead Sciences Inc

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing …

Sector
Healthcare
Market Cap
$138B
Forward P/E
14.5x
Employees
17,600

Get Instant GILD Catalyst Alerts

Receive an email alert when GILD triggers an unusual volume breakout, options sweep, or rating shift.

Other Liquid Stocks Moving Today

All Today's Movers

GILD Session & Catalyst FAQ

Why is GILD stock trading near flat today?

Gilead Sciences Inc (GILD) is trading within a tight intraday band at $166.53 (-1.45%, 0.81x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, GILD is outperforming the S&P 500 by +0.51%. 14-day RSI stands at 55.8, keeping momentum in a bullish regime.

Is GILD stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 0.81x relative volume (low participation). Our multi-factor model currently rates GILD as HOLD. Review full valuation, quality, and timing signals on the GILD Buy or Sell Decision Brief →

What is GILD's intrinsic value and expected trading range?

At $166.53, GILD's modeled 1-to-3 session range is $160.27 – $172.79, with a key inflection level at $166.80 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the GILD Intrinsic Value & DCF Model → and Market Cycle Phase Tracker →

What do RSI and moving averages signal for GILD?

RSI at 55.8 reflects constructive bullish momentum. GILD trades at $166.53 relative to its 20-day SMA ($166.80) and 50-day SMA ($156.82), reflecting a bullish moving-average structure.

Tradestie Flagship Research & Market Hubs